Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

40,763 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
miR-15a/16-1 deletion in activated B cells promotes plasma cell and mature B-cell neoplasms.
Sewastianik T, Straubhaar JR, Zhao JJ, Samur MK, Adler K, Tanton HE, Shanmugam V, Nadeem O, Dennis PS, Pillai V, Wang J, Jiang M, Lin J, Huang Y, Brooks D, Bouxsein M, Dorfman DM, Pinkus GS, Robbiani DF, Ghobrial IM, Budnik B, Jarolim P, Munshi NC, Anderson KC, Carrasco RD. Sewastianik T, et al. Among authors: lin j. Blood. 2021 Apr 8;137(14):1905-1919. doi: 10.1182/blood.2020009088. Blood. 2021. PMID: 33751108 Free PMC article.
MicroRNA-221/222 negatively regulates estrogen receptor alpha and is associated with tamoxifen resistance in breast cancer.
Zhao JJ, Lin J, Yang H, Kong W, He L, Ma X, Coppola D, Cheng JQ. Zhao JJ, et al. Among authors: lin j. J Biol Chem. 2008 Nov 7;283(45):31079-86. doi: 10.1074/jbc.M806041200. Epub 2008 Sep 12. J Biol Chem. 2008. Retraction in: J Biol Chem. 2016 Oct 21;291(43):22859. doi: 10.1074/jbc.A116.806041 PMID: 18790736 Free PMC article. Retracted.
Bruton tyrosine kinase inhibition is a novel therapeutic strategy targeting tumor in the bone marrow microenvironment in multiple myeloma.
Tai YT, Chang BY, Kong SY, Fulciniti M, Yang G, Calle Y, Hu Y, Lin J, Zhao JJ, Cagnetta A, Cea M, Sellitto MA, Zhong MY, Wang Q, Acharya C, Carrasco DR, Buggy JJ, Elias L, Treon SP, Matsui W, Richardson P, Munshi NC, Anderson KC. Tai YT, et al. Among authors: lin j. Blood. 2012 Aug 30;120(9):1877-87. doi: 10.1182/blood-2011-12-396853. Epub 2012 Jun 11. Blood. 2012. PMID: 22689860 Free PMC article.
miR-30-5p functions as a tumor suppressor and novel therapeutic tool by targeting the oncogenic Wnt/β-catenin/BCL9 pathway.
Zhao JJ, Lin J, Zhu D, Wang X, Brooks D, Chen M, Chu ZB, Takada K, Ciccarelli B, Admin S, Tao J, Tai YT, Treon S, Pinkus G, Kuo WP, Hideshima T, Bouxsein M, Munshi N, Anderson K, Carrasco R. Zhao JJ, et al. Among authors: lin j. Cancer Res. 2014 Mar 15;74(6):1801-13. doi: 10.1158/0008-5472.CAN-13-3311-T. Epub 2014 Mar 5. Cancer Res. 2014. PMID: 24599134 Free PMC article.
Targeting the miR-221-222/PUMA/BAK/BAX Pathway Abrogates Dexamethasone Resistance in Multiple Myeloma.
Zhao JJ, Chu ZB, Hu Y, Lin J, Wang Z, Jiang M, Chen M, Wang X, Kang Y, Zhou Y, Ni Chonghaile T, Johncilla ME, Tai YT, Cheng JQ, Letai A, Munshi NC, Anderson KC, Carrasco RD. Zhao JJ, et al. Among authors: lin j. Cancer Res. 2015 Oct 15;75(20):4384-4397. doi: 10.1158/0008-5472.CAN-15-0457. Epub 2015 Aug 6. Cancer Res. 2015. PMID: 26249174 Free PMC article.
Tolerance, Kinetics, and Depth of Response for Subcutaneous Versus Intravenous Administration of Bortezomib Combination in Chinese Patients With Newly Diagnosed Multiple Myeloma.
Xu Y, Deng S, Mao X, An G, Li Z, Wang Y, Fulciniti M, Ho M, Lin J, Sui W, Liu W, Zou D, Yi S, Huang W, Liu H, Lv R, Li J, Wang T, Du C, Munshi NC, Qiu L. Xu Y, et al. Among authors: lin j. Clin Lymphoma Myeloma Leuk. 2018 Jun;18(6):422-430. doi: 10.1016/j.clml.2018.03.006. Epub 2018 Mar 15. Clin Lymphoma Myeloma Leuk. 2018. PMID: 29625927 Free PMC article.
40,763 results
You have reached the last available page of results. Please see the User Guide for more information.